Through the comparison of various clinical indicators between T2DM macaques and T2DM patients, it is clearly found that all of them have experienced obesity, compensatory increase in fasting insulin, reduced postprandial glucose clearance, and decreased insulin secretion, significantly [16]. The gene discussed is INS; the disease is Obesity.